Physician profile
Aubrey C Galloway
NPI 1982696696
$5,726,915.98
in general payments reported to CMS, 2019-2025
10 companies · $425K in 2025
The $425K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.1M · 2020: $982K · 2021: $1.1M · 2022: $1.1M · 2023: $558K · 2024: $413K · 2025: $425K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,395,265.00 |
| Food and Beverage | $698.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,656,996.88 | 2021-2025 | Contour 3d, Cg Future, Profile 3d |
| Medtronic Vascular, INC. | $2,038,082.54 | 2019-2020 | |
| Edwards Lifesciences Corporation | $31,069.24 | 2019-2024 | |
| Abbott Laboratories | $267.72 | 2022-2024 | Epic, Navitor |
| Baxter Healthcare | $194.04 | 2022-2025 | Floseal, Perclot, Tisseel |
| Abiomed | $167.33 | 2021 | |
| Pfizer INC. | $48.51 | 2025 | |
| Atricure, INC. | $42.89 | 2025 | Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals, Ltd. | $24.37 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.46 | 2025 | A&E Medical / Sternalock Xp Rigid Fixation System, Sternalock Blu System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubrey Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.